Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Adverum Biotechnologies Inc (ADVM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adverum Biotechn's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.670 +0.140    +1.21%
15:14:43 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 42,322
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 11.460 - 12.015
Adverum Biotechn 11.670 +0.140 +1.21%

Adverum Biotechnologies Inc Company Profile

 
Get an in-depth profile of Adverum Biotechnologies Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

123

Equity Type

ORD

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Contact Information

Address 100 Cardinal Way
Redwood City, 94063
United States
Phone 650 656 9323
Fax 650 649 1995

Top Executives

Name Age Since Title
C. Patrick Machado 59 2017 Independent Chairman
Dawn A. Svoronos 70 2020 Independent Director
James Paul Scopa 64 2019 Independent Director
Laurent Fischer 59 2020 President, CEO & Director
Szilard Kiss - - Scientific Advisory Board Member
Mark L. Lupher 52 2019 Independent Director
Soo J. Hong 51 2022 Independent Director
Reed Vaughn Tuckson 72 2021 Independent Director
Scott M. Whitcup 64 2020 Independent Director
David S. Boyer - - Scientific Advisory Board Member
Arshad M. Khanani - - Scientific Advisory Board Member
Charles C. Wykoff - - Scientific Advisory Board Member
Rabia Gurses Ozden 55 2022 Independent Director
Jeffrey S. Heier 62 - Scientific Advisory Board Member
C. David Nicholson 68 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADVM Comments

Write your thoughts about Adverum Biotechnologies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
fer lui
fer lui Dec 09, 2022 12:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My God, what a shame and shame for the company and managers!!!!
fer lui
fer lui Oct 28, 2022 2:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The shame of the nasdaq!!!!
Tahir Saaed
Tahir Saaed Feb 22, 2022 2:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thsi stock goign all way doen to 0...... Get out before its to late
Cecile Mesime
Cecile Mesime Jan 13, 2022 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's going on?
Shahan Khan
Shahan Khan Oct 18, 2021 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy...?
marcel magem
marcel magem Jun 07, 2021 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long term investment
Joseph Marzullo
Joseph Marzullo May 07, 2021 11:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great bargain buy right now
Joseph Marzullo
Joseph Marzullo May 07, 2021 11:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great bargain!!
Hajy Yosef
Hajy Yosef Apr 30, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is not a stocks
Anh Tai Dang
Anh Tai Dang Apr 30, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why ?
marcel magem
marcel magem Apr 29, 2021 7:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good oportunity to.buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email